BBNX: Beta Bionics, Inc. insider trading, 5% holders and institutional ownership
From public SEC filings: open-market insider purchases and sales (Form 4, last 180 days), holders of 5% or more (Schedules 13D and 13G) and institutional ownership (Form 13F). Insider and 5% data delayed 48 hours.
Insider trading
0 open-market buys totaling - and 2 sales totaling $20K in the last 180 days.
Insider sales
| Trade date | Insider | Role | Value | 10b5-1 plan |
|---|---|---|---|---|
| 2026-10-14 | Hopman Mark | Officer | $13K | |
| 2026-10-01 | Hopman Mark | Officer | $7K |
Activist and 5% holders
| Filed | What | Holder | Stake | Change | Filing |
|---|---|---|---|---|---|
| 2026-10-07 | New 13G stake | T. Rowe Price Associates, Inc. | 16.60% | SEC | |
| 2026-08-13 | Fell below 5% | Farallon Capital Management, L.L.C. | 1.30% | SEC |
Get new insider and activist filings the morning after: daily alerts. Not investment advice.